nal product does not require any special storage conditions.
6.5 Nature and contents of container
PVC-aluminium/paper child-resistant foil blister pack/s containing 12 tablets.
6.6 Special precautions for disposal and other handling
No special requirements.
Any unused medicinal product or waste material should be disposed of in accordance with local requirements.
7. Marketing authorisation holder
Glaxo Wellcome UK Ltd, trading as GlaxoSmithKline UK.
Stockley Park West
Uxbridge
Middlesex
UB11 1BT
8. Marketing authorisation number(s)
PL 10949/0258
9. Date of first authorisation/renewal of the authorisation
Date of first authorisation: 21 October 1996.
Date of latest renewal: 18 October 2011.
10. Date of revision of the text
